eGenesis just raised $191M from a stellar group of investors betting on a future where 'dialysis becomes obsolete.'
Signals Brief: Why Lux Capital is Betting Big on CRISPR and the Future of Organ Transplants
Signals Brief: Why Lux Capital is Betting Big…
Signals Brief: Why Lux Capital is Betting Big on CRISPR and the Future of Organ Transplants
eGenesis just raised $191M from a stellar group of investors betting on a future where 'dialysis becomes obsolete.'